Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-NRP1A antibodies and their uses for treating eye or ocular diseases

Anti-NRP1A antibodies and their uses for treating eye or ocular diseases

US Patent 11661458 · Granted May 30, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucagon analogues as long-acting GLP-1/glucagon receptor agonists in the treatm2025
Anti-C3 antibodies and antigen-binding fragments thereof and their uses for trea2025
Anti-PD-1 antibodies2025
Anti-PD-1 antibodies2025
Tri-specific binding molecules2025
Multi-specific binding proteins for cancer treatment2024
Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer2024
Pharmaceutical composition, methods for treating and uses thereof2024
Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye di2024
Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye di2024
Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye di2024
Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof2024